Onglyza approved in EU in combination with other diabetes drugs

10/5/2009 | Google

European regulators approved AstraZeneca and Bristol-Myers Squibb's diabetes medicine Onglyza as a combination treatment with metformin or two other standard drugs for Type 2 diabetes. The companies plan to roll out Onglyza in the EU by the end of the year.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI